title: Resolution of Roth spots in chronic myeloid leukaemia after treatment with imatinib.
authors.affiliation: Department of Haematology at Norfolk & Norwich University Hospital NHS Trust, Norwich, UK. suzanne.docherty@nnuh.nhs.uk.
authors.forename: Suzanne M
authors.initials: SM
authors.lastname: Docherty
authors.affiliation: Department of Ophthalmology, Norfolk and Norwich University Hospital NHS Trust, Norwich, UK.
authors.forename: Moosavi
authors.initials: M
authors.lastname: Reza
authors.affiliation: Department of Haematology at Norfolk & Norwich University Hospital NHS Trust, Norwich, UK.
authors.forename: Gillian
authors.initials: G
authors.lastname: Turner
authors.affiliation: Department of Haematology at Norfolk & Norwich University Hospital NHS Trust, Norwich, UK.
authors.forename: Kristian
authors.initials: K
authors.lastname: Bowles
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy; D008297:Male; D019721:Ophthalmoscopes; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012164:Retinal Diseases / Q000175:diagnosis / Q000473:pathology*; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D000068877:Imatinib Mesylate